Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PROCEPT BioRobotics (PRCT) Revenue (2020 - 2025)

PROCEPT BioRobotics (PRCT) has disclosed Revenue for 6 consecutive years, with $76.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Revenue rose 11.94% to $76.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $308.1 million, a 37.22% increase, with the full-year FY2025 number at $308.1 million, up 37.22% from a year prior.
  • Revenue was $76.4 million for Q4 2025 at PROCEPT BioRobotics, down from $83.3 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $83.3 million in Q3 2025 to a low of $7.2 million in Q1 2021.
  • A 5-year average of $38.9 million and a median of $34.1 million in 2023 define the central range for Revenue.
  • Peak YoY movement for Revenue: skyrocketed 672.39% in 2021, then rose 11.94% in 2025.
  • PROCEPT BioRobotics' Revenue stood at $10.1 million in 2021, then skyrocketed by 134.56% to $23.8 million in 2022, then soared by 83.29% to $43.6 million in 2023, then surged by 56.57% to $68.2 million in 2024, then grew by 11.94% to $76.4 million in 2025.
  • Per Business Quant, the three most recent readings for PRCT's Revenue are $76.4 million (Q4 2025), $83.3 million (Q3 2025), and $79.2 million (Q2 2025).